Find clinical trials for Insmed. Search for Insmed clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 7
Active & Responsive
A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants
for
Healthy Volunteers
Location: Salt Lake City UT
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 50
Code: NCT07765706
Phase 1, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07481981
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
for
Amyotrophic Lateral Sclerosis
Location: Worcester MA, Philadelphia PA, Baltimore MD,
Sponsor: Insmed Gene Therapy LLC
Sex: All
Age: 18 - 70+
Code: NCT07290062
Phase 1, Recruiting
New
A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Naples FL, Bend OR
Sponsor: Insmed Incorporated
Sex: All
Age: 18+
Code: NCT07234032
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
for
Hepatic Impairment
Location: Orlando FL, San Antonio TX, San Dimas CA,
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 70
Code: NCT07643155
Phase 1, Recruiting
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension, Interstitial Lung Disease
Location: New York NY, Philadelphia PA, Richmond VA, Durham NC,